Entry of influenza A virus: Host factors and antiviral targets

Journal of General Virology

Volumn 95, Issue PART 2, 2014, Pages 263-277

  Edinger, Thomas O ^a   Pohl, Marie O ^a   Stertz, Silke ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMANTANE; AMANTADINE; ANTIBODY; BAFILOMYCIN A1; HOST FACTOR; RIBONUCLEOPROTEIN; RIMANTADINE; SIALIC ACID; VIRUS RECEPTOR;

ANTIVIRAL ACTIVITY; CELL NUCLEUS; CYTOPLASM; ENDOCYTOSIS; ENDOSOME; HOST CELL; INFLUENZA VIRUS A; INTERNALIZATION; NONHUMAN; NUCLEAR IMPORT; PATHOGENESIS; PINOCYTOSIS; PRIORITY JOURNAL; REVIEW; TARGET CELL; VIRION; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS GENOME; VIRUS REPLICATION; VIRUS UNCOATING;

ANIMALS; ANTIVIRAL AGENTS; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS; VIRUS INTERNALIZATION;

EID: 84892608409     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.059477-0     Document Type: Review

References (178)

1. Baum, L. G. & Paulson, J. C. (1990). Sialyloligosaccharides of the respiratory epithelium in the selection of human influenza virus receptor specificity. Acta Histochem Suppl 40, 35-38.
2. Bodian, D. L., Yamasaki, R. B., Buswell, R. L., Stearns, J. F., White, J. M. & Kuntz, I. D. (1993). Inhibition of the fusion-inducing conformational change of influenza hemagglutinin by benzoquinones and hydroquinones. Biochemistry 32, 2967-2978.
3. Bourmakina, S. V. & García-Sastre, A. (2003). Reverse genetics studies on the filamentous morphology of influenza A virus. J Gen Virol 84, 517-527.
4. Bowman, E. J., Siebers, A. & Altendorf, K. (1988). Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc Natl Acad Sci U S A 85, 7972-7976.
5. Bright, R. A., Medina, M. J., Xu, X., Perez-Oronoz, G., Wallis, T. R., Davis, X. M., Povinelli, L., Cox, N. J. & Klimov, A. I. (2005). Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 366, 1175-1181.
6. Bucci, C., Parton, R. G., Mather, I. H., Stunnenberg, H., Simons, K., Hoflack, B. & Zerial, M. (1992). The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway. Cell 70, 715-728.
7. Bui, M., Whittaker, G. & Helenius, A. (1996). Effect of M1 protein and low pH on nuclear transport of influenza virus ribonucleoproteins. J Virol 70, 8391-8401.
8. Bukrinskaya, A. G., Vorkunova, N. K., Kornilayeva, G. V., Narmanbetova, R. A. & Vorkunova, G. K. (1982). Influenza virus uncoating in infected cells and effect of rimantadine. J Gen Virol 60, 49-59.
9. Bullido, R., Gómez-Puertas, P., Albo, C. & Portela, A. (2000). Several protein regions contribute to determine the nuclear and cytoplasmic localization of the influenza A virus nucleoprotein. J Gen Virol 81, 135-142.
10. Bullough, P. A., Hughson, F. M., Skehel, J. J. & Wiley, D. C. (1994). Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371, 37-43.
11. Calder, L. J., Wasilewski, S., Berriman, J. A. & Rosenthal, P. B. (2010). Structural organization of a filamentous influenza A virus. Proc Natl Acad Sci U S A 107, 10685-10690.
12. Carr, C. M. & Kim, P. S. (1993). A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell 73, 823-832.
13. Carroll, S. M. & Paulson, J. C. (1985). Differential infection of receptormodified host cells by receptor-specific influenza viruses. Virus Res 3, 165-179.
14. Chandrasekaran, A., Srinivasan, A., Raman, R., Viswanathan, K., Raguram, S., Tumpey, T. M., Sasisekharan, V. & Sasisekharan, R. (2008). Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat Biotechnol 26, 107-113.
15. Chen, C. & Zhuang, X. (2008). Epsin 1 is a cargo-specific adaptor for the clathrin-mediated endocytosis of the influenza virus. Proc Natl Acad Sci U S A 105, 11790-11795.
16. 2 subunit to form an N cap that terminates the triple-stranded coiled coil. Proc Natl Acad Sci U S A 96, 8967-8972.
17. Chernomordik, L. V., Frolov, V. A., Leikina, E., Bronk, P. & Zimmerberg, J. (1998). The pathway of membrane fusion catalyzed by influenza hemagglutinin: restriction of lipids, hemifusion, and lipidic fusion pore formation. J Cell Biol 140, 1369-1382.
18. Chizhmakov, I. V., Geraghty, F. M., Ogden, D. C., Hayhurst, A., Antoniou, M. & Hay, A. J. (1996). Selective proton permeability and pH regulation of the influenza virus M2 channel expressed in mouse erythroleukaemia cells. J Physiol 494, 329-336.
19. Chou, Y. Y., Heaton, N. S., Gao, Q., Palese, P., Singer, R. & Lionnet, T. (2013). Colocalization of different influenza viral RNA segments in the cytoplasm before viral budding as shown by single-molecule sensitivity FISH analysis. PLoS Pathog 9, e1003358.
20. Christoforidis, S., McBride, H. M., Burgoyne, R. D. & Zerial, M. (1999a). The Rab5 effector EEA1 is a core component of endosome docking. Nature 397, 621-625.
21. Christoforidis, S., Miaczynska, M., Ashman, K., Wilm, M., Zhao, L., Yip, S. C., Waterfield, M. D., Backer, J. M. & Zerial, M. (1999b). Phosphatidylinositol-3-OH kinases are Rab5 effectors. Nat Cell Biol 1, 249-252.
22. Chu, V. C. & Whittaker, G. R. (2004). Influenza virus entry and infection require host cell N-linked glycoprotein. Proc Natl Acad Sci U S A 101, 18153-18158.
23. Clementi, N., Criscuolo, E., Castelli, M., Mancini, N., Clementi, M. & Burioni, R. (2012). Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range antiinfluenza vaccines. Viruses 4, 3090-3108.
24. Cocucci, E., Aguet, F., Boulant, S. & Kirchhausen, T. (2012). The first five seconds in the life of a clathrin-coated pit. Cell 150, 495-507.
25. Connor, R. J., Kawaoka, Y., Webster, R. G. & Paulson, J. C. (1994). Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology 205, 17-23.
26. Corti, D. & Lanzavecchia, A. (2013). Broadly neutralizing antiviral antibodies. Annu Rev Immunol 31, 705-742.
27. Corti, D., Voss, J., Gamblin, S. J., Codoni, G., Macagno, A., Jarrossay, D., Vachieri, S. G., Pinna, D., Minola, A. & other authors (2011). A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333, 850-856.
28. Cros, J. F. & Palese, P. (2003). Trafficking of viral genomic RNA into and out of the nucleus: influenza, Thogoto and Borna disease viruses. Virus Res 95, 3-12.
29. Daniels, R. S., Downie, J. C., Hay, A. J., Knossow, M., Skehel, J. J., Wang, M. L. & Wiley, D. C. (1985). Fusion mutants of the influenza virus hemagglutinin glycoprotein. Cell 40, 431-439.
30. Davies, W. L., Grunert, R. R., Haff, R. F., McGahen, J. W., Neumayer, E. M., Paulshock, M., Watts, J. C., Wood, T. R., Hermann, E. C. & Hoffmann, C. E. (1964). Antiviral activity of 1-adamantanamine (amantadine). Science 144, 862-863.
31. De Conto, F., Covan, S., Arcangeletti, M. C., Orlandini, G., Gatti, R., Dettori, G. & Chezzi, C. (2011). Differential infectious entry of human influenza A/NWS/33 virus (H1N1) in mammalian kidney cells. Virus Res 155, 221-230.
32. De Conto, F., Di Lonardo, E., Arcangeletti, M. C., Chezzi, C., Medici, M. C. & Calderaro, A. (2012). Highly dynamic microtubules improve the effectiveness of early stages of human influenza A/NWS/33 virus infection in LLC-MK2 cells. PLoS ONE 7, e41207.
33. de Vries, E., Tscherne, D. M., Wienholts, M. J., Cobos-Jiménez, V., Scholte, F., García-Sastre, A., Rottier, P. J. & de Haan, C. A. (2011). Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway. PLoS Pathog 7, e1001329.
34. de Vries, E., de Vries, R. P., Wienholts, M. J., Floris, C. E., Jacobs, M. S., van den Heuvel, A., Rottier, P. J. & de Haan, C. A. (2012). Influenza A virus entry into cells lacking sialylated N-glycans. Proc Natl Acad Sci U S A 109, 7457-7462.
35. Durrer, P., Galli, C., Hoenke, S., Corti, C., Glück, R., Vorherr, T. & Brunner, J. (1996). H+-induced membrane insertion of influenza virus hemagglutinin involves the HA2 amino-terminal fusion peptide but not the coiled coil region. J Biol Chem 271, 13417-13421.
36. Eierhoff, T., Hrincius, E. R., Rescher, U., Ludwig, S. & Ehrhardt, C. (2010). The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells. PLoS Pathog 6, e1001099.
37. Ekiert, D. C. & Wilson, I. A. (2012). Broadly neutralizing antibodies against influenza virus and prospects for universal therapies. Curr Opin Virol 2, 134-141.
38. Ekiert, D. C., Bhabha, G., Elsliger, M. A., Friesen, R. H., Jongeneelen, M., Throsby, M., Goudsmit, J. & Wilson, I. A. (2009). Antibody recognition of a highly conserved influenza virus epitope. Science 324, 246-251.
39. Ekiert, D. C., Kashyap, A. K., Steel, J., Rubrum, A., Bhabha, G., Khayat, R., Lee, J. H., Dillon, M. A., O'Neil, R. E. & other authors (2012). Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature 489, 526-532.
40. Elleman, C. J. & Barclay, W. S. (2004). The M1 matrix protein controls the filamentous phenotype of influenza A virus. Virology 321, 144-153.
41. Elster, C., Fourest, E., Baudin, F., Larsen, K., Cusack, S. & Ruigrok, R. W. (1994). A small percentage of influenza virus M1 protein contains zinc but zinc does not influence in vitro M1-RNA interaction. J Gen Virol 75, 37-42.
42. Fontana, J. & Steven, A. C. (2013). At low pH, influenza virus matrix protein M1 undergoes a conformational change prior to dissociating from the membrane. J Virol 87, 5621-5628.
43. Fontana, J., Cardone, G., Heymann, J. B., Winkler, D. C. & Steven, A. C. (2012). Structural changes in Influenza virus at low pH characterized by cryo-electron tomography. J Virol 86, 2919-2929.
44. Forgac, M. (2007). Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat Rev Mol Cell Biol 8, 917-929.
45. Fujioka, Y., Tsuda, M., Hattori, T., Sasaki, J., Sasaki, T., Miyazaki, T. & Ohba, Y. (2011). The Ras-PI3K signaling pathway is involved in clathrin-independent endocytosis and the internalization of influenza viruses. PLoS ONE 6, e16324.
46. Galloway, C. J., Dean, G. E., Marsh, M., Rudnick, G. & Mellman, I. (1983). Acidification of macrophage and fibroblast endocytic vesicles in vitro. Proc Natl Acad Sci U S A 80, 3334-3338.
47. Galloway, S. E., Reed, M. L., Russell, C. J. & Steinhauer, D. A. (2013). Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation. PLoS Pathog 9, e1003151.
48. Gambaryan, A. S., Tuzikov, A. B., Pazynina, G. V., Desheva, J. A., Bovin, N. V., Matrosovich, M. N. & Klimov, A. I. (2008). 6-Sulfo sialyl Lewis X is the common receptor determinant recognized by H5, H6, H7 and H9 influenza viruses of terrestrial poultry. Virol J 5, 85.
49. Gamblin, S. J., Haire, L. F., Russell, R. J., Stevens, D. J., Xiao, B., Ha, Y., Vasisht, N., Steinhauer, D. A., Daniels, R. S. & other authors (2004). The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science 303, 1838-1842.
50. Gottlieb, T. A., Ivanov, I. E., Adesnik, M. & Sabatini, D. D. (1993). Actin microfilaments play a critical role in endocytosis at the apical but not the basolateral surface of polarized epithelial cells. J Cell Biol 120, 695-710.
51. Grambas, S., Bennett, M. S. & Hay, A. J. (1992). Influence of amantadine resistance mutations on the pH regulatory function of the M2 protein of influenza A viruses. Virology 191, 541-549.
52. Guinea, R. & Carrasco, L. (1995). Requirement for vacuolar proton-ATPase activity during entry of influenza virus into cells. J Virol 69, 2306-2312.
53. Hay, A. J., Wolstenholme, A. J., Skehel, J. J. & Smith, M. H. (1985). The molecular basis of the specific anti-influenza action of amantadine. EMBO J 4, 3021-3024.
54. Hay, A. J., Zambon, M. C., Wolstenholme, A. J., Skehel, J. J. & Smith, M. H. (1986). Molecular basis of resistance of influenza A viruses to amantadine. J Antimicrob Chemother 18 (Suppl B), 19-29.
55. Hayden, F. G., Sperber, S. J., Belshe, R. B., Clover, R. D., Hay, A. J. & Pyke, S. (1991). Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine. Antimicrob Agents Chemother 35, 1741-1747.
56. He, J., Sun, E., Bujny, M. V., Kim, D., Davidson, M. W. & Zhuang, X. (2013). Dual function of CD81 in influenza virus uncoating and budding. PLoS Pathog 9, e1003701.
57. Hendricks, G. L., Weirich, K. L., Viswanathan, K., Li, J., Shriver, Z. H., Ashour, J., Ploegh, H. L., Kurt-Jones, E. A., Fygenson, D. K. & other authors (2013). Sialylneolacto-N-tetraose c (LSTc)-bearing liposomal decoys capture influenza A virus. J Biol Chem 288, 8061-8073.
58. 2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds. Virology 183, 32-43.
59. Huang, R. T., Lichtenberg, B. & Rick, O. (1996). Involvement of annexin V in the entry of influenza viruses and role of phospholipids in infection. FEBS Lett 392, 59-62.
60. Huotari, J. & Helenius, A. (2011). Endosome maturation. EMBO J 30, 3481-3500.
61. Huotari, J., Meyer-Schaller, N., Hubner, M., Stauffer, S., Katheder, N., Horvath, P., Mancini, R., Helenius, A. & Peter, M. (2012). Cullin-3 regulates late endosome maturation. Proc Natl Acad Sci U S A 109, 823-828.
62. Huss, M. & Wieczorek, H. (2009). Inhibitors of V-ATPases: old and new players. J Exp Biol 212, 341-346.
63. Hutchinson, E. C. & Fodor, E. (2012). Nuclear import of the influenza A virus transcriptional machinery. Vaccine 30, 7353-7358.
64. Imai, M. & Kawaoka, Y. (2012). The role of receptor binding specificity in interspecies transmission of influenza viruses. Curr Opin Virol 2, 160-167.
65. Ito, T., Suzuki, Y., Suzuki, T., Takada, A., Horimoto, T., Wells, K., Kida, H., Otsuki, K., Kiso, M. & other authors (2000). Recognition of Nglycolylneuraminic acid linked to galactose by the a 2, 3 linkage is associated with intestinal replication of influenza A virus in ducks. J Virol 74, 9300-9305.
66. Kemler, I., Whittaker, G. & Helenius, A. (1994). Nuclear import of microinjected influenza virus ribonucleoproteins. Virology 202, 1028-1033.
67. Kesimer, M., Scull, M., Brighton, B., DeMaria, G., Burns, K., O'Neal, W., Pickles, R. J. & Sheehan, J. K. (2009). Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense. FASEB J 23, 1858-1868.
68. Kimura, K., Mori, S., Tomita, K., Ohno, K., Takahashi, K., Shigeta, S. & Terada, M. (2000). Antiviral activity of NMSO3 against respiratory syncytial virus infection in vitro and in vivo. Antiviral Res 47, 41-51.
69. Koivusalo, M., Welch, C., Hayashi, H., Scott, C. C., Kim, M., Alexander, T., Touret, N., Hahn, K. M. & Grinstein, S. (2010). Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. J Cell Biol 188, 547-563.
70. König, R., Stertz, S., Zhou, Y., Inoue, A., Hoffmann, H. H., Bhattacharyya, S., Alamares, J. G., Tscherne, D. M., Ortigoza, M. B. & other authors (2010). Human host factors required for influenza virus replication. Nature 463, 813-817.
71. Korte, T., Ludwig, K., Booy, F. P., Blumenthal, R. & Herrmann, A. (1999). Conformational intermediates and fusion activity of influenza virus hemagglutinin. J Virol 73, 4567-4574.
72. Lakadamyali, M., Rust, M. J., Babcock, H. P. & Zhuang, X. (2003). Visualizing infection of individual influenza viruses. Proc Natl Acad Sci U S A 100, 9280-9285.
73. Lamb, R. A. & Choppin, P. W. (1981). Identification of a second protein (M2) encoded by RNA segment 7 of influenza virus. Virology 112, 729-737.
74. Leikina, E., Ramos, C., Markovic, I., Zimmerberg, J. & Chernomordik, L. V. (2002). Reversible stages of the low-pH-triggered conformational change in influenza virus hemagglutinin. EMBO J 21, 5701-5710.
75. Leneva, I. A., Russell, R. J., Boriskin, Y. S. & Hay, A. J. (2009). Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol. Antiviral Res 81, 132-140.
76. Liu, J., Stevens, D. J., Haire, L. F., Walker, P. A., Coombs, P. J., Russell, R. J., Gamblin, S. J. & Skehel, J. J. (2009). Structures of receptor complexes formed by hemagglutinins from the Asian influenza pandemic of 1957. Proc Natl Acad Sci U S A 106, 17175-17180.
77. Londrigan, S. L., Turville, S. G., Tate, M. D., Deng, Y. M., Brooks, A. G. & Reading, P. C. (2011). N-Linked glycosylation facilitates sialic acidindependent attachment and entry of influenza A viruses into cells expressing DC-SIGN or L-SIGN. J Virol 85, 2990-3000.
78. Luo, G., Torri, A., Harte, W. E., Danetz, S., Cianci, C., Tiley, L., Day, S., Mullaney, D., Yu, K. L. & other authors (1997). Molecular mechanism underlying the action of a novel fusion inhibitor of influenza A virus. J Virol 71, 4062-4070.
79. Luzio, J. P., Pryor, P. R. & Bright, N. A. (2007). Lysosomes: fusion and function. Nat Rev Mol Cell Biol 8, 622-632.
80. Maeda, T. & Ohnishi, S. (1980). Activation of influenza virus by acidic media causes hemolysis and fusion of erythrocytes. FEBS Lett 122, 283-287.
81. Markovic, I., Leikina, E., Zhukovsky, M., Zimmerberg, J. & Chernomordik, L. V. (2001). Synchronized activation and refolding of influenza hemagglutinin in multimeric fusion machines. J Cell Biol 155, 833-844.
82. Martin, K. & Helenius, A. (1991). Transport of incoming influenza virus nucleocapsids into the nucleus. J Virol 65, 232-244.
83. Martinez, O., Tsibane, T. & Basler, C. F. (2009). Neutralizing antiinfluenza virus monoclonal antibodies: therapeutics and tools for discovery. Int Rev Immunol 28, 69-92.
84. Matlin, K. S., Reggio, H., Helenius, A. & Simons, K. (1981). Infectious entry pathway of influenza virus in a canine kidney cell line. J Cell Biol 91, 601-613.
85. Matrosovich, M., Stech, J. & Klenk, H. D. (2009). Influenza receptors, polymerase and host range. Rev Sci Tech 28, 203-217.
86. Matsubara, T., Sumi, M., Kubota, H., Taki, T., Okahata, Y. & Sato, T. (2009). Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library. J Med Chem 52, 4247-4256.
87. Matsubara, T., Onishi, A., Saito, T., Shimada, A., Inoue, H., Taki, T., Nagata, K., Okahata, Y. & Sato, T. (2010). Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy. J Med Chem 53, 4441-4449.
88. Maxfield, F. R. & Yamashiro, D. J. (1987). Endosome acidification and the pathways of receptor-mediated endocytosis. Adv Exp Med Biol 225, 189-198.
89. Melen, K., Fagerlund, R., Franke, J., Kohler, M., Kinnunen, L. & Julkunen, I. (2003). Importin a nuclear localization signal binding sites for STAT1, STAT2, and influenza A virus nucleoprotein. J Biol Chem 278, 28193-28200.
90. Melikyan, G. B., Niles, W. D. & Cohen, F. S. (1993a). Influenza virus hemagglutinin-induced cell-planar bilayer fusion: quantitative dissection of fusion pore kinetics into stages. J Gen Physiol 102, 1151-1170.
91. Melikyan, G. B., Niles, W. D., Peeples, M. E. & Cohen, F. S. (1993b). Influenza hemagglutinin-mediated fusion pores connecting cells to planar membranes: flickering to final expansion. J Gen Physiol 102, 1131-1149.
92. Mellman, I. (1996). Endocytosis and molecular sorting. Annu Rev Cell Dev Biol 12, 575-625.
93. Mu, F. T., Callaghan, J. M., Steele-Mortimer, O., Stenmark, H., Parton, R. G., Campbell, P. L., McCluskey, J., Yeo, J. P., Tock, E. P. & Toh, B. H. (1995). EEA1, an early endosome-associated protein. EEA1 is a conserved a-helical peripheral membrane protein flanked by cysteine "fingers" and contains a calmodulin-binding IQ motif. J Biol Chem 270, 13503-13511.
94. Müller, K. H., Kainov, D. E., El Bakkouri, K., Saelens, X., De Brabander, J. K., Kittel, C., Samm, E. & Muller, C. P. (2011). The proton translocation domain of cellular vacuolar ATPase provides a target for the treatment of influenza A virus infections. Br J Pharmacol 164, 344-357.
95. Nicholls, J. M., Moss, R. B. & Haslam, S. M. (2013). The use of sialidase therapy for respiratory viral infections. Antiviral Res 98, 401-409.
96. Nicol, M. Q., Ligertwood, Y., Bacon, M. N., Dutia, B. M. & Nash, A. A. (2012). A novel family of peptides with potent activity against influenza A viruses. J Gen Virol 93, 980-986.
97. Nielsen, E., Severin, F., Backer, J. M., Hyman, A. A. & Zerial, M. (1999). Rab5 regulates motility of early endosomes on microtubules. Nat Cell Biol 1, 376-382.
98. Noton, S. L., Medcalf, E., Fisher, D., Mullin, A. E., Elton, D. & Digard, P. (2007). Identification of the domains of the influenza A virus M1 matrix protein required for NP binding, oligomerization and incorporation into virions. J Gen Virol 88, 2280-2290.
99. O'Neill, R. E., Jaskunas, R., Blobel, G., Palese, P. & Moroianu, J. (1995). Nuclear import of influenza virus RNA can be mediated by viral nucleoprotein and transport factors required for protein import. J Biol Chem 270, 22701-22704.
100. Ochiai, H., Sakai, S., Hirabayashi, T., Shimizu, Y. & Terasawa, K. (1995). Inhibitory effect of bafilomycin A1, a specific inhibitor of vacuolar-type proton pump, on the growth of influenza A and B viruses in MDCK cells. Antiviral Res 27, 425-430.
101. Okada, A., Miura, T. & Takeuchi, H. (2003). Zinc-and pH-dependent conformational transition in a putative interdomain linker region of the influenza virus matrix protein M1. Biochemistry 42, 1978-1984.
102. Okuno, Y., Isegawa, Y., Sasao, F. & Ueda, S. (1993). A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J Virol 67, 2552-2558.
103. Palese, P. & Shaw, M. L. (2007). Orthomyxoviridae: the viruses and their replication. In Fields Virology, 5th edn, pp. 1647-1689. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams and Wilkins.
104. Patterson, S., Oxford, J. S. & Dourmashkin, R. R. (1979). Studies on the mechanism of influenza virus entry into cells. J Gen Virol 43, 223-229.
105. +-ATPase in animal virus entry. J Gen Virol 75, 2595-2606.
106. Pinto, L. H., Holsinger, L. J. & Lamb, R. A. (1992). Influenza virus M2 protein has ion channel activity. Cell 69, 517-528.
107. Plotch, S. J., O'Hara, B., Morin, J., Palant, O., LaRocque, J., Bloom, J. D., Lang, S. A., Jr, DiGrandi, M. J., Bradley, M. & other authors (1999). Inhibition of influenza A virus replication by compounds interfering with the fusogenic function of the viral hemagglutinin. J Virol 73, 140-151.
108. Rabinovich, S., Baldini, J. T. & Bannister, R. (1969). Treatment of influenza. The therapeutic efficacy of rimantadine HC1 in a naturally occurring influenza A2 outbreak. Am J Med Sci 257, 328-335.
109. Reading, P. C., Miller, J. L. & Anders, E. M. (2000). Involvement of the mannose receptor in infection of macrophages by influenza virus. J Virol 74, 5190-5197.
110. Rink, J., Ghigo, E., Kalaidzidis, Y. & Zerial, M. (2005). Rab conversion as a mechanism of progression from early to late endosomes. Cell 122, 735-749.
111. Roberts, P. C., Garten, W. & Klenk, H. D. (1993). Role of conserved glycosylation sites in maturation and transport of influenza A virus hemagglutinin. J Virol 67, 3048-3060.
112. Roberts, P. C., Lamb, R. A. & Compans, R. W. (1998). The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation. Virology 240, 127-137.
113. Roberts, K. L., Shelton, H., Scull, M., Pickles, R. & Barclay, W. S. (2011). Lack of transmission of a human influenza virus with avian receptor specificity between ferrets is not due to decreased virus shedding but rather a lower infectivity in vivo. J Gen Virol 92, 1822-1831.
114. Rossman, J. S. & Lamb, R. A. (2011). Influenza virus assembly and budding. Virology 411, 229-236.
115. Rossman, J. S., Leser, G. P. & Lamb, R. A. (2012). Filamentous influenza virus enters cells via macropinocytosis. J Virol 86, 10950-10960.
116. Roy, A. M., Parker, J. S., Parrish, C. R. & Whittaker, G. R. (2000). Early stages of influenza virus entry into Mv-1 lung cells: involvement of dynamin. Virology 267, 17-28.
117. Ruigrok, R. W., Barge, A., Durrer, P., Brunner, J., Ma, K. & Whittaker, G. R. (2000). Membrane interaction of influenza virus M1 protein. Virology 267, 289-298.
118. Russell, R. J., Kerry, P. S., Stevens, D. J., Steinhauer, D. A., Martin, S. R., Gamblin, S. J. & Skehel, J. J. (2008). Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion. Proc Natl Acad Sci U S A 105, 17736-17741.
119. Rust, M. J., Lakadamyali, M., Zhang, F. & Zhuang, X. (2004). Assembly of endocytic machinery around individual influenza viruses during viral entry. Nat Struct Mol Biol 11, 567-573.
120. Sauter, N. K., Bednarski, M. D., Wurzburg, B. A., Hanson, J. E., Whitesides, G. M., Skehel, J. J. & Wiley, D. C. (1989). Hemagglutinins from two influenza virus variants bind to sialic acid derivatives with millimolar dissociation constants: a 500-MHz proton nuclear magnetic resonance study. Biochemistry 28, 8388-8396.
121. Schmitt, A. P. & Lamb, R. A. (2005). Influenza virus assembly and budding at the viral budozone. Adv Virus Res 64, 383-416.
122. Sieczkarski, S. B. & Whittaker, G. R. (2002). Influenza virus can enter and infect cells in the absence of clathrin-mediated endocytosis. J Virol 76, 10455-10464.
123. Sieczkarski, S. B. & Whittaker, G. R. (2003). Differential requirements of Rab5 and Rab7 for endocytosis of influenza and other enveloped viruses. Traffic 4, 333-343.
124. Sieczkarski, S. B. & Whittaker, G. R. (2005). Characterization of the host cell entry of filamentous influenza virus. Arch Virol 150, 1783-1796.
125. Sieczkarski, S. B., Brown, H. A. & Whittaker, G. R. (2003). Role of protein kinase C betaII in influenza virus entry via late endosomes. J Virol 77, 460-469.
126. Simonsen, A., Lippé, R., Christoforidis, S., Gaullier, J. M., Brech, A., Callaghan, J., Toh, B. H., Murphy, C., Zerial, M. & Stenmark, H. (1998). EEA1 links PI (3) K function to Rab5 regulation of endosome fusion. Nature 394, 494-498.
127. Skehel, J. J. & Wiley, D. C. (2000). Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69, 531-569.
128. Skehel, J. J., Hay, A. J. & Armstrong, J. A. (1978). On the mechanism of inhibition of influenza virus replication by amantadine hydrochloride. J Gen Virol 38, 97-110.
129. Spruce, A. E., Iwata, A., White, J. M. & Almers, W. (1989). Patch clamp studies of single cell-fusion events mediated by a viral fusion protein. Nature 342, 555-558.
130. Steinhauer, D. A. (2013). Influenza: pathways to human adaptation. Nature 499, 412-413.
131. Steinman, R. M., Mellman, I. S., Muller, W. A. & Cohn, Z. A. (1983). Endocytosis and the recycling of plasma membrane. J Cell Biol 96, 1-27.
132. Stevens, J., Blixt, O., Glaser, L., Taubenberger, J. K., Palese, P., Paulson, J. C. & Wilson, I. A. (2006a). Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Mol Biol 355, 1143-1155.
133. Stevens, J., Blixt, O., Tumpey, T. M., Taubenberger, J. K., Paulson, J. C. & Wilson, I. A. (2006b). Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312, 404-410.
134. Stouffer, A. L., Acharya, R., Salom, D., Levine, A. S., Di Costanzo, L., Soto, C. S., Tereshko, V., Nanda, V., Stayrook, S. & DeGrado, W. F. (2008). Structural basis for the function and inhibition of an influenza virus proton channel. Nature 451, 596-599.
135. Stray, S. J., Cummings, R. D. & Air, G. M. (2000). Influenza virus infection of desialylated cells. Glycobiology 10, 649-658.
136. Su, W. C., Chen, Y. C., Tseng, C. H., Hsu, P. W., Tung, K. F., Jeng, K. S. & Lai, M. M. (2013). Pooled RNAi screen identifies ubiquitin ligase Itch as crucial for influenza A virus release from the endosome during virus entry. Proc Natl Acad Sci U S A 110, 17516-17521.
137. Sugrue, R. J. & Hay, A. J. (1991). Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel. Virology 180, 617-624.
138. Sui, J., Hwang, W. C., Perez, S., Wei, G., Aird, D., Chen, L. M., Santelli, E., Stec, B., Cadwell, G. & other authors (2009). Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 16, 265-273.
139. Sun, X. & Whittaker, G. R. (2007). Role of the actin cytoskeleton during influenza virus internalization into polarized epithelial cells. Cell Microbiol 9, 1672-1682.
140. Sun, X., Shi, Y., Lu, X., He, J., Gao, F., Yan, J., Qi, J. & Gao, G. F. (2013). Bat-derived influenza hemagglutinin H17 does not bind canonical avian or human receptors and most likely uses a unique entry mechanism. Cell Rep 3, 769-778.
141. Sweet, C., Hayden, F. G., Jakeman, K. J., Grambas, S. & Hay, A. J. (1991). Virulence of rimantadine-resistant human influenza A (H3N2) viruses in ferrets. J Infect Dis 164, 969-972.
142. Tatulian, S. A., Hinterdorfer, P., Baber, G. & Tamm, L. K. (1995). Influenza hemagglutinin assumes a tilted conformation during membrane fusion as determined by attenuated total reflection FTIR spectroscopy. EMBO J 14, 5514-5523.
143. Terabayashi, T., Morita, M., Ueno, M., Nakamura, T. & Urashima, T. (2006). Inhibition of influenza-virus-induced cytopathy by sialylglycoconjugates. Carbohydr Res 341, 2246-2253.
144. Thompson, C. I., Barclay, W. S., Zambon, M. C. & Pickles, R. J. (2006). Infection of human airway epithelium by human and avian strains of influenza A virus. J Virol 80, 8060-8068.
145. + memory B cells. PLoS ONE 3, e3942.
146. Tong, S., Li, Y., Rivailler, P., Conrardy, C., Castillo, D. A., Chen, L. M., Recuenco, S., Ellison, J. A., Davis, C. T. & other authors (2012). A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci U S A 109, 4269-4274.
147. Tong, S., Zhu, X., Li, Y., Shi, M., Zhang, J., Bourgeois, M., Yang, H., Chen, X., Recuenco, S. & other authors (2013). New world bats harbor diverse influenza a viruses. PLoS Pathog 9, e1003657.
148. 2-terminal segment during influenza virus-induced membrane fusion. J Biol Chem 267, 20225-20232.
149. Upham, J. P., Pickett, D., Irimura, T., Anders, E. M. & Reading, P. C. (2010). Macrophage receptors for influenza A virus: role of the macrophage galactose-type lectin and mannose receptor in viral entry. J Virol 84, 3730-3737.
150. Vanderlinden, E., Göktas, F., Cesur, Z., Froeyen, M., Reed, M. L., Russell, C. J., Cesur, N. & Naesens, L. (2010). Novel inhibitors of influenza virus fusion: structure-activity relationship and interaction with the viral hemagglutinin. J Virol 84, 4277-4288.
151. Vanderlinden, E. & Naesens, L. (2013). Emerging antiviral strategies to interfere with influenza virus entry. Med Res Rev (in press).
152. Vigant, F., Lee, J., Hollmann, A., Tanner, L. B., Akyol Ataman, Z., Yun, T., Shui, G., Aguilar, H. C., Zhang, D. & other authors (2013). A mechanistic paradigm for broad-spectrum antivirals that target viruscell fusion. PLoS Pathog 9, e1003297.
153. Wang, C., Takeuchi, K., Pinto, L. H. & Lamb, R. A. (1993). Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block. J Virol 67, 5585-5594.
154. Wang, P., Palese, P. & O'Neill, R. E. (1997). The NPI-1/NPI-3 (karyopherin a) binding site on the influenza a virus nucleoprotein NP is a nonconventional nuclear localization signal. J Virol 71, 1850-1856.
155. Wang, S. F., Huang, J. C., Lee, Y. M., Liu, S. J., Chan, Y. J., Chau, Y. P., Chong, P. & Chen, Y. M. (2008). DC-SIGN mediates avian H5N1 influenza virus infection in cis and in trans. Biochem Biophys Res Commun 373, 561-566.
156. Wang, J., Ma, C., Wang, J., Jo, H., Canturk, B., Fiorin, G., Pinto, L. H., Lamb, R. A., Klein, M. L. & DeGrado, W. F. (2013). Discovery of novel dual inhibitors of the wild-type and the most prevalent drug-resistant mutant, S31N, of the M2 proton channel from influenza A virus. J Med Chem 56, 2804-2812.
157. +-induced insertion of influenza hemagglutinin HA2 N-terminal segment into viral membrane. J Biol Chem 269, 18353-18358.
158. Weber, F., Kochs, G., Gruber, S. & Haller, O. (1998). A classical bipartite nuclear localization signal on Thogoto and influenza A virus nucleoproteins. Virology 250, 9-18.
159. Weis, W., Brown, J. H., Cusack, S., Paulson, J. C., Skehel, J. J. & Wiley, D. C. (1988). Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature 333, 426-431.
160. Wharton, S. A., Belshe, R. B., Skehel, J. J. & Hay, A. J. (1994). Role of virion M2 protein in influenza virus uncoating: specific reduction in the rate of membrane fusion between virus and liposomes by amantadine. J Gen Virol 75, 945-948.
161. White, J. M. & Wilson, I. A. (1987). Anti-peptide antibodies detect steps in a protein conformational change: low-pH activation of the influenza virus hemagglutinin. J Cell Biol 105, 2887-2896.
162. Whittle, J. R., Zhang, R., Khurana, S., King, L. R., Manischewitz, J., Golding, H., Dormitzer, P. R., Haynes, B. F., Walter, E. B. & other authors (2011). Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc Natl Acad Sci U S A 108, 14216-14221.
163. Wilks, S., de Graaf, M., Smith, D. J. & Burke, D. F. (2012). A review of influenza haemagglutinin receptor binding as it relates to pandemic properties. Vaccine 30, 4369-4376.
164. Wolf, M. C., Freiberg, A. N., Zhang, T., Akyol-Ataman, Z., Grock, A., Hong, P. W., Li, J., Watson, N. F., Fang, A. Q. & other authors (2010). A broad-spectrum antiviral targeting entry of enveloped viruses. Proc Natl Acad Sci U S A 107, 3157-3162.
165. Xiong, X., Coombs, P. J., Martin, S. R., Liu, J., Xiao, H., McCauley, J. W., Locher, K., Walker, P. A., Collins, P. J. & other authors (2013a). Receptor binding by a ferret-transmissible H5 avian influenza virus. Nature 497, 392-396.
166. Xiong, X., Martin, S. R., Haire, L. F., Wharton, S. A., Daniels, R. S., Bennett, M. S., McCauley, J. W., Collins, P. J., Walker, P. A. & other authors (2013b). Receptor binding by an H7N9 influenza virus from humans. Nature 499, 496-499.
167. Xu, R., McBride, R., Paulson, J. C., Basler, C. F. & Wilson, I. A. (2010). Structure, receptor binding, and antigenicity of influenza virus hemagglutinins from the 1957 H2N2 pandemic. J Virol 84, 1715-1721.
168. Yamauchi, Y., Boukari, H., Banerjee, I., Sbalzarini, I. F., Horvath, P. & Helenius, A. (2011). Histone deacetylase 8 is required for centrosome cohesion and influenza A virus entry. PLoS Pathog 7, e1002316.
169. Yoshida, R., Igarashi, M., Ozaki, H., Kishida, N., Tomabechi, D., Kida, H., Ito, K. & Takada, A. (2009). Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses. PLoS Pathog 5, e1000350.
170. Yoshimoto, J., Kakui, M., Iwasaki, H., Fujiwara, T., Sugimoto, H. & Hattori, N. (1999). Identification of a novel HA conformational change inhibitor of human influenza virus. Arch Virol 144, 865-878.
171. Yoshimura, A., Kuroda, K., Kawasaki, K., Yamashina, S., Maeda, T. & Ohnishi, S. (1982). Infectious cell entry mechanism of influenza virus. J Virol 43, 284-293.
172. Zebedee, S. L. & Lamb, R. A. (1988). Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. J Virol 62, 2762-2772.
173. Zerial, M. & McBride, H. (2001). Rab proteins as membrane organizers. Nat Rev Mol Cell Biol 2, 107-117.
174. Zhang, J. & Lamb, R. A. (1996). Characterization of the membrane association of the influenza virus matrix protein in living cells. Virology 225, 255-266.
175. Zhirnov, O. P. (1990). Solubilization of matrix protein M1/M from virions occurs at different pH for orthomyxo-and paramyxoviruses. Virology 176, 274-279.
176. Zhu, L., Li, Y., Li, S., Li, H., Qiu, Z., Lee, C., Lu, H., Lin, X., Zhao, R. & other authors (2011). Inhibition of influenza A virus (H1N1) fusion by benzenesulfonamide derivatives targeting viral hemagglutinin. PLoS ONE 6, e29120.
177. Zhu, L., Ly, H. & Liang, Y. (2013a). PLC-c1 signaling plays a subtypespecific role in post-binding cell entry of influenza A virus. J Virol [Epub ahead of print].
178. Zhu, X., Yu, W., McBride, R., Li, Y., Chen, L. M., Donis, R. O., Tong, S., Paulson, J. C. & Wilson, I. A. (2013b). Hemagglutinin homologue from H17N10 bat influenza virus exhibits divergent receptor-binding and pH-dependent fusion activities. Proc Natl Acad Sci U S A 110, 1458-1463.